Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

40.76
+4.5712.63%
Post-market: 40.00-0.7600-1.86%19:12 EDT
Volume:3.23M
Turnover:129.69M
Market Cap:3.21B
PE:-8.62
High:40.92
Open:39.40
Low:37.94
Close:36.19
Loading ...
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 31, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 29, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 16, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 06, 2022

Major Issues Report

8-K - Current report